FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108617005: Zileuton (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173151019 Zileuton en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
602773011 Zileuton (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
25751000188114 Zileuton fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zileuton Is a Product containing leukotriene receptor antagonist (product) false Inferred relationship Some
Zileuton Is a Smooth muscle relaxant false Inferred relationship Some
Zileuton Is a Leukotriene receptor antagonist false Inferred relationship Some
Zileuton Is a Smooth muscle relaxant (substance) false Inferred relationship Some
Zileuton Is a 5-lipoxygenase inhibitor true Inferred relationship Some
Zileuton Is a Respiratory smooth muscle relaxant false Inferred relationship Some
Zileuton This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. 5-lipoxygenase inhibitor (disposition) true Inferred relationship Some
Zileuton Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Zileuton Is a Enzyme inhibitor false Inferred relationship Some
Zileuton Is a Bronchodilator (substance) true Inferred relationship Some
Zileuton Is a Bicyclic compound (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Zileuton 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zileuton Inferred relationship Some
Product containing zileuton (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zileuton Inferred relationship Some 1
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zileuton Inferred relationship Some
Zileuton 600 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zileuton Inferred relationship Some 1
Zileuton 600 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zileuton Inferred relationship Some 1
Zileuton-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zileuton Inferred relationship Some 1
Zileuton 600 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zileuton Inferred relationship Some 1
Product containing only zileuton (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zileuton Inferred relationship Some 1
Product containing only zileuton in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zileuton Inferred relationship Some 1
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zileuton Inferred relationship Some 1
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zileuton Inferred relationship Some 1

This concept is not in any reference sets

Back to Start